Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 10 Similar Profiles
Pulmonary Hypertension Medicine & Life Sciences
Lung Medicine & Life Sciences
Xanthine Dehydrogenase Medicine & Life Sciences
Endothelial cells Chemical Compounds
Apoptosis Medicine & Life Sciences
Endothelial Cells Medicine & Life Sciences
Macrophage Migration-Inhibitory Factors Chemical Compounds
Systemic Scleroderma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2018

Imatinib Is Protective Against Ischemia-Reperfusion Injury in an Ex Vivo Rabbit Model of Lung Injury

Magruder, J. T., Grimm, J. C., Crawford, T. C., Johnston, L., Santhanam, L., Stephens, R. S., Berkowitz, D. E., Shah, A. S., Bush, E. L., Damarla, M., Damico, R. L., Hassoun, P. M. & Kim, B. S. Mar 1 2018 In : Annals of Thoracic Surgery. 105, 3, p. 950-956 7 p.

Research output: Contribution to journalArticle

Lung Injury
Reperfusion Injury
Rabbits
Lung
Bronchoalveolar Lavage

Improvement in right ventricular strain with ambrisentan and tadalafil upfront therapy in scleroderma-associated pulmonary arterial hypertension

Mercurio, V., Mukherjee, M., Tedford, R. J., Zamanian, R. T., Khair, R. M., Sato, T., Minai, O. A., Torres, F., Girgis, R. E., Chin, K., Damico, R., Kolb, T. M., Mathai, S. C. & Hassoun, P. M. Feb 1 2018 In : American journal of respiratory and critical care medicine. 197, 3, p. 388-391 4 p.

Research output: Contribution to journalLetter

Pulmonary Hypertension
Therapeutics
ambrisentan
Tadalafil

The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study

Sato, T., Ambale-Venkatesh, B., Lima, J. A. C., Zimmerman, S. L., Tedford, R. J., Fujii, T., Hulme, O. L., Pullins, E. H., Corona-Villalobos, C. P., Zamanian, R. T., Minai, O. A., Girgis, R. E., Chin, K., Khair, R., Damico, R. L., Kolb, T. M., Mathai, S. C. & Hassoun, P. M. Feb 1 2018 In : Pulmonary Circulation. 8, 1

Research output: Contribution to journalArticle

Pulmonary Hypertension
Right Ventricular Function
Magnetic Resonance Spectroscopy
Left Ventricular Function
Systemic Scleroderma

Evaluation of criteria for exerciseinduced pulmonary hypertension in patients with resting pulmonary hypertension

Mullin, C. J., Hsu, S., Amancherla, K., Wand, A., Rhodes, P., Leary, P. J., Mukherjee, M., Damico, R. L., Kolb, T. M., Mathai, S. C., Hassoun, P. M. & Tedford, R. J. Sep 1 2017 In : European Respiratory Journal. 50, 3, 00784

Research output: Contribution to journalLetter

Pulmonary Hypertension

Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction

Bourji, K. I., Kelemen, B. W., Mathai, S. C., Damico, R. L., Kolb, T. M., Mercurio, V., Cozzi, F., Tedford, R. J. & Hassoun, P. M. 2017 In : Pulmonary Circulation. 7, 2, p. 409-420 12 p.

Research output: Contribution to journalArticle

Systemic Scleroderma
Pulmonary Hypertension
Heart Failure
Survival
Cardiac Catheterization